arrow
S

Satoshi Yamamoto

Chiba Cancer Center
H指数:40
被引数:5,729

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy

在转移性激素敏感前列腺癌患者接受三联疗法时,术前长期去势可降低发热性中性粒细胞减少症的发生

2026-02-010
PRE
Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis

PSA水平与骨转移体积之间的不一致与不良预后相关

2025-11-010
PRE
The Efficacy and safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin, 5-FU therapy for resectable locally advanced esophageal squamous cell carcinoma

新辅助多西他赛联合顺铂、5-FU疗法后,辅助纳武利尤单抗疗法在可切除局部晚期食管鳞状细胞癌中的有效性与安全性

2024-12-010
PRE
FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML

FLT3抑制剂和造血干细胞移植可延长FLT3-ITD-positive AML患者的生存期

2024-11-301
PRE
High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia
2022-05-259
OAAI
A novel nutritional index simplified CONUT and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia
2020-11-1012
OAAI
Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases
2020-08-218
PREAI
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma
2020-04-044
PREAI
A role for IL-34 in osteolytic disease of multiple myeloma
2019-02-1923
OA